Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
2
×
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
2
×
detroit blog main
detroit top stories
fda
2
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
2
×
wisconsin top stories
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
arena pharmaceuticals
athenex
biomarin pharmaceutical
biotech
bluebird bio
cancer
cardiovascular disease
What
drug
2
×
fda
patients
2
×
aren’t
bio
cancer
developers
drugs
eisai
flags
gene
help
higher
imminent
incidence
long
lorcaserin
loss
market
marketing
medicare
medicine
moves
news
noteworthy
post
prices
pulls
risks
road
roundup
rulings
separate
study
therapy
they’ll
took
weight
winding
withdrawing
Language
unset
Current search:
drug
×
patients
×
fda
×
" boston blog main "
×
" wisconsin blog main "
×
" clinical trials "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More